To explore our 2015 Life Sciences Trends Report, download the PDF here or view an abbreviated overview below. In 2015, ...

Over the last two years, Clarkston Consulting has released its study on Quality in Generic Pharmaceuticals. As in the past, ...

As populations in emerging markets grow and their economies improve, so will the demand for quality, affordable health care. In ...

An article published this month in New York Magazine highlights the recent advancements to the regenerative medicine and medical device ...

Although appearing dead for now, the $106 billion associated with Pfizer’s proposed buyout of AstraZeneca makes it hard to ignore ...

In 2013, US Customs & Border Protection seized more than 2,350 parcels containing counterfeit medical devices and pharmaceutical products valued ...

Together, industry regulations and healthcare reform are impacting how pharmaceutical companies do business. Drug makers are experiencing a heavy financial ...

The hype around 3D printing rose spectacularly in 2013, and with continued progress, it has the potential to revolutionize the ...

Healthcare reforms, shifting market demands, and increasing regulatory pressures are transforming the life sciences industry on a global scale. Patients, ...

The 2nd International Summit on GMP, GCP & Quality Control took place recently at the DoubleTree by Hilton Hotel Chicago ...

The annual meeting of the Bio Supply Management Alliance was held on October 8th, 2013, and was well-attended by key ...

The FDA has recently proposed new labeling requirements for generic pharmaceutical companies. Current regulations do not allow generics companies to ...